Caris Life Sciences (CAI) Adds New AI-powered Breast Cancer Signature to its Report

​Caris Life Sciences, Inc. (NASDAQ:CAI) is one of the Best All-Time Low Stocks to Invest In Now. On February 24, Caris Life Sciences, Inc. (NASDAQ:CAI) announced that it is adding a new AI-powered “breast cancer signature” to its Caris Molecular Tumor Board Report. The report is a research tool that doctors and researchers use for additional tumor biology resources and can be ordered with the company’s MI Cancer Seek.

​Management noted that the report will now include a “Caris AI Insights” section with signatures powered by artificial intelligence. These signatures help in predicting how HER2-negative breast cancer patients will respond to capecitabine as first-line treatment. The AI has been trained on data from more than 2,000 gene expression and includes features from patients’ Whole Exome Sequencing and Whole Transcriptome Sequencing. Moreover, these signatures can also assist in identifying tissue of origin, assessing metastasis risk, and guiding personalized treatment strategies for patients.

Caris Life Sciences (CAI) Adds New AI-powered Breast Cancer Signature to its Report

Pressmaster/Shutterstock.com

MI Cancer Seek was approved by the FDA in November 2024 as the first tissue-based test combining Whole Exome Sequencing and Whole Transcriptome Sequencing for solid tumors.

​Caris Life Sciences, Inc. (NASDAQ:CAI) is an artificial intelligence TechBio company that provides molecular profiling services and develops solutions using molecular information and machine learning algorithms in the United States and internationally.

While we acknowledge the potential of CAI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CAI and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.